PAULSON & CO. INC.: BAUSCH HEALTH COS INC (BHC): Quarterly 13F Position History
As of Q2 2026, PAULSON & CO. INC. reported 73,255,869 shares of BAUSCH HEALTH COS INC (BHC), worth $361.2M and representing 14.0% of its 13F equity book. The position first appeared in Q3 2018 and has been disclosed across 32 13F-HR filings in Pactolio's tracked window.
- 73,255,869Shares Held (Latest Filing)
- $361.2MReported Market Value (Latest Filing)
- 14.0%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$34.4MQuarter-over-Quarter Value Change
- 73,255,869Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 32 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 73,255,869 | 0 | – | $361.2M | 14.0% | $4.9 |
| Q1 2026 | 73,255,869 | 0 | – | $395.6M | 12.7% | $5.4 |
| Q4 2025 | 73,255,869 | +2,500,000 | +3.5% | $509.1M | 15.6% | $7.0 |
| Q3 2025 | 70,755,869 | +37,964,167 | +115.8% | $456.4M | 15.4% | $6.5 |
| Q2 2025 | 32,791,702 | +6,352,667 | +24.0% | $218.4M | 10.9% | $6.7 |
| Q1 2025 | 26,439,035 | 0 | – | $171.1M | 9.8% | $6.5 |
| Q4 2024 | 26,439,035 | 0 | – | $213.1M | 12.9% | $8.1 |
| Q3 2024 | 26,439,035 | 0 | – | $215.7M | 15.1% | $8.2 |
| Q2 2024 | 26,439,035 | 0 | – | $184.3M | 13.6% | $7.0 |
| Q1 2024 | 26,439,035 | 0 | – | $280.5M | 19.4% | $10.6 |
| Q4 2023 | 26,439,035 | 0 | – | $212.0M | 19.1% | $8.0 |
| Q3 2023 | 26,439,035 | 0 | – | $217.3M | 19.4% | $8.2 |
| Q2 2023 | 26,439,035 | 0 | – | $211.5M | 20.6% | $8.0 |
| Q1 2023 | 26,439,035 | 0 | – | $214.2M | 17.8% | $8.1 |
| Q4 2022 | 26,439,035 | 0 | – | $166.0M | 14.9% | $6.3 |
| Q3 2022 | 26,439,035 | 0 | – | $182.2M | 13.3% | $6.9 |
| Q2 2022 | 26,439,035 | +600,000 | +2.3% | $221.0M | 10.9% | $8.4 |
| Q1 2022 | 25,839,035 | 0 | – | $590.4M | 18.2% | $22.9 |
| Q4 2021 | 25,839,035 | 0 | – | $713.4M | 22.0% | $27.6 |
| Q3 2021 | 25,839,035 | 0 | – | $719.6M | 20.5% | $27.9 |
| Q2 2021 | 25,839,035 | 0 | – | $757.6M | 18.1% | $29.3 |
| Q1 2021 | 25,839,035 | 0 | – | $820.1M | 18.8% | $31.7 |
| Q4 2020 | 25,839,035 | 0 | – | $537.5M | 14.0% | $20.8 |
| Q3 2020 | 25,839,035 | 0 | – | $401.5M | 12.5% | $15.5 |
| Q2 2020 | 25,839,035 | +5,000,000 | +24.0% | $472.6M | 15.1% | $18.3 |
| Q1 2020 | 20,839,035 | 0 | – | $323.0M | 12.3% | $15.5 |
| Q4 2019 | 20,839,035 | 0 | – | $623.5M | 13.5% | $29.9 |
| Q3 2019 | 20,839,035 | 0 | – | $455.3M | 9.3% | $21.9 |
| Q2 2019 | 20,839,035 | 0 | – | $525.6M | 9.4% | $25.2 |
| Q1 2019 | 20,839,035 | 0 | – | $514.7M | 11.4% | $24.7 |
| Q4 2018 | 20,839,035 | 0 | – | $384.9M | 9.2% | $18.5 |
| Q3 2018 | 20,839,035 | – | – | $534.9M | 10.0% | $25.7 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did PAULSON & CO. INC. first disclose a BHC position in 13F-HR filings?
PAULSON & CO. INC. first reported BAUSCH HEALTH COS INC (BHC) on its 13F-HR filing for the period ending 2018-09-30 (Q3 2018). The position has appeared on 32 reported quarters within Pactolio's tracked window.
What was PAULSON & CO. INC.'s most recent quarter-over-quarter share-count change in BHC?
PAULSON & CO. INC. held the same 73,255,869 shares of BHC between Q1 2026 and Q2 2026, so the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent PAULSON & CO. INC.'s cost basis in BHC?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.